IMMUNOFRONTIER INC.

immunofrontier-inc-logo

ImmunoFrontier, Inc. a Japanese drug discovery venture company. ImmunoFrontier, Inc. aims to develop innovative immune therapies with higher efficacy and few side effects for the wide range of cancers, especially the hard-to-treat esophageal, prostate and lung cancers and for the treatment of intractable immune diseases.

#SimilarOrganizations #People #Website #More

IMMUNOFRONTIER INC.

Industry:
Biotechnology Health Care Pharmaceutical

Address:
Tokyo, Tokyo, Japan

Country:
Japan

Website Url:
http://www.immunofrontier.com

Total Employee:
11+

Status:
Active

Contact:
+81-(0)3-5777-0710

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress


Similar Organizations

pharmadesign-logo

PharmaDesign

PharmaDesign is a genomic drug discovery venture company.

proteomedix-frontiers-logo

Proteomedix Frontiers

Proteomedix Frontiers is drug discovery and development company.

Current Employees Featured

not_available_image

Miyamoto Hiroshi
Miyamoto Hiroshi President & CEO @ ImmunoFrontier Inc.
President & CEO
2018-01-01

Official Site Inspections

http://www.immunofrontier.com

  • Host name: sv8156.xserver.jp
  • IP address: 183.181.88.157
  • Location: Osaka Japan
  • Latitude: 34.6848
  • Longitude: 135.5142
  • Timezone: Asia/Tokyo
  • Postal: 543-0062

Loading ...

More informations about "ImmunoFrontier Inc."

About us โ€“ ImmunoFrontier

Oct 5, 2004 ImmunoFrontier was founded in 2004 as a bio-venture company originating from Mie University. Since then, we have focused on the development of therapeutic cancer โ€ฆSee details»

ImmunoFrontier โ€“ ImmunoFrontier

Based on this, ImmunoFrontier, Inc. aims to develop innovative immune therapies with higher efficacy and few side effects against the wide range of cancers, especially the hard-to-treat โ€ฆSee details»

ImmunoFrontier Inc. - Crunchbase Company Profile & Funding

ImmunoFrontier Inc. is a Japanese drug discovery venture company. ImmunoFrontier, Inc. a Japanese drug discovery venture company. ImmunoFrontier, Inc. aims to develop innovative โ€ฆSee details»

ImmunoFrontier โ€“ ImmunoFrontier

21ไธ–็ด€ใซๅ…ฅใ‚Šใ€้ฉๆ–ฐ็š„ใชใŒใ‚“ๆฒป็™‚ๆณ•ใฎ้–‹็™บใŒไธ–็•Œ็š„ใซ็››ใ‚“ใซใชใฃใฆใ„ใพใ™ใ€‚ใใฎๆฝฎๆตใฎใฒใจใคใจใ—ใฆใ€ไบบไฝ“ใซๅ…ƒใ€…ๅ‚™ใ‚ใฃใฆใ„ใ‚‹ใ€Œๅ…็–ซใ€ใ‚’ๅˆฉ็”จใ™ ใ‚‹ๆŠ—ไฝ“ๅŒป่–ฌใ‚„ใŒใ‚“ใƒฏใ‚ฏใƒใƒณใŒๆณจ็›ฎใ‚’้›†ใ‚ โ€ฆSee details»

IMMUNOFRONTIER,INC. Company Profile - Dun & Bradstreet

IMMUNOFRONTIER,INC. Company Profile | OSAKA, OSAKA, Japan | Competitors, Financials & Contacts - Dun & BradstreetSee details»

IMMUNOFRONTIER,INC. Company Profile - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for IMMUNOFRONTIER,INC. of TSU, MIE. Get the latest business insights from Dun & Bradstreet.See details»

ImmunoFrontier, Inc. - Drug pipelines, Patents, Clinical trials

Last update 02 May 2024. ImmunoFrontier, Inc. Holding Company |See details»

ImmunoFrontier - Overview, News & Similar companies - ZoomInfo

Who is ImmunoFrontier. We are dedicated to the accurate, objective, and transparent reporting of scientific and clinical information and hope to provide a free resource f or the general public, โ€ฆSee details»

ImmunoFrontier, Inc. - Products, Competitors, Financials, โ€ฆ

Feb 5, 2010 ImmunoFrontier, Inc. is a biotech venture focused on the development of innovative immunotherapy treatments for cancer and immune diseases. The company specializes in โ€ฆSee details»

ImmunoFrontier Inc. - Contacts, Employees, Board Members

Organization. ImmunoFrontier Inc. Connect to CRM . Save . Summary. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 1. About. ImmunoFrontier โ€ฆSee details»

ImmunoFrontier - Company Profile - Tracxn

Oct 23, 2024 ImmunoFrontier - Protein and DNA vaccines for the treatment of cancer.. Raised funding from 1 investor. ImmunoFrontier has 2949 competitors.See details»

Business Operation โ€“ ImmunoFrontier

While ImmunoFrontier, Inc has several core technologies, โ€œCHP technologyโ€ is expected to be put into practical use ealiest of all. Wide range of application is now in progress to CHP cancer โ€ฆSee details»

ImmunoFrontier Inc. - Tech Stack, Apps, Patents & Trademarks

ImmunoFrontier Inc. is actively using 3 technologies for its website, according to BuiltWith. These include SPF , Xserver , and Xserver DNS . Website Tech Stack by BuiltWithSee details»

Cancer vaccine(ImmunoFrontier, Inc.) - Drug Targets, Indications ...

A phase I+II clinical trial of vaccination with MAGE-A4 protein complexed with cholesteryl pullulan melanoma antigen gene-A4 nanogel (CHP-MAGE-A4) is currently underway in patients with โ€ฆSee details»

Introduction โ€“ ImmunoFrontier

Based on this, ImmunoFrontier, Inc. aims to develop innovative immune therapies with higher efficacy and few side effects against the wide range of cancers, especially the hard-to-treat โ€ฆSee details»

IMMUNOFRONTIER INC innovation strategy - GoodIP

IMMUNOFRONTIER INC has a total of 16 patent applications. Its first patent ever was published in 2002. It filed its patents most often in EPO (European Patent Office), Australia and โ€ฆSee details»

Dose-dependent effects of NY-ESO-1 protein vaccine complexed โ€ฆ

CHP-NY-ESO-1 complex vaccine (Drug code: IMF-001) was provided by ImmunoFrontier, Inc. (Tokyo, Japan). All processes were performed following current Good Manufacturing Practices โ€ฆSee details»

Research programme: cancer vaccines - ImmunoFrontier

ImmunoFrontier is developing DNA and protein based cancer vaccines, which will produce an immune response directed against a number of tumour antigens. Research programme: โ€ฆSee details»

ImmunoFrontierโ€™s bussiness goals โ€“ ImmunoFrontier

Urban Ace Higashitenma-BLDG.,1-1-19, Higashitenma,Kita-ku,Osaka,530-0044,JapanSee details»

Drug Discovery for Multifunctional Cancer DNA Vaccines

Jan 1, 2019 We are developing novel, next generation vaccines based on DNA immunization with multifunctional genes. In this technology, DNA vaccine carrying multiple genes encoding โ€ฆSee details»

linkstock.net © 2022. All rights reserved